Management of hepatic encephalopathy as an inpatient
Oliviero Riggio, Silvia Nardelli, Stefania Gioia, Cristina Lucidi, Manuela Merli – 21 April 2015 – Watch a video presentation of this article
Impact of minimal/covert hepatic encephalopathy on patients with cirrhosis
Radha K. Dhiman – 21 April 2015 – Watch a video presentation of this article
Hepatology highlights
Jean‐François Dufour – 20 April 2015
Hepatology highlights
Jean‐François Dufour – 20 April 2015
Resminostat: Opening the door to epigenetic treatments for liver cancer
Jun Zhao, Matthew W. Lawless – 18 April 2015
Value anti–hepatitis C virus therapy by its clinical efficacy
Adriaan J. van der Meer – 18 April 2015
GNPAT Variant associated with severe iron overload in HFE hemochromatosis
Edouard Bardou‐Jacquet, Marie de Tayrac, Jean Mosser, Yves Deugnier – 18 April 2015
Circulating Kidney Injury Molecule 1 Predicts Prognosis and Poor Outcome in Patients With Acetaminophen‐Induced Liver Injury
Daniel J. Antoine, Venkata S. Sabbisetti, Ben Francis, Andrea L. Jorgensen, Darren G.N. Craig, Kenneth J. Simpson, Joseph V. Bonventre, B. Kevin Park, James W. Dear – 18 April 2015 – Acute kidney injury in the context of acetaminophen (APAP; paracetamol)‐induced liver injury is an important predictor of the requirement for urgent liver transplantation (LT) to avoid death. However, the prognostic biomarker used to report kidney dysfunction (serum creatinine concentration) has suboptimal sensitivity and specificity.
Does IL‐22 protect against liver fibrosis in hepatitis C virus infection?
Liyuan Wu, Jingmin Zhao – 18 April 2015
Alcoholic hepatitis: Can we outwit the Grim Reaper?
Sakkarin Chirapongsathorn, Patrick S. Kamath, Vijay Shah – 18 April 2015